Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jay Spiegel"'
Autor:
Matthew J. Frank, John Baird, Anne Kramer, Shabnum Patel, Bita Sahaf, Juliana Craig, Emma Crawford, Sheren Younes, Jean Oak, Yasodha Natkunan, Jay Spiegel, Zachary Ehlinger, Harshini Chinnasamy, Warren Reynolds, Hrishi Srinagesh, Yi-Jiun Su, Emily Egeler, Steven Feldman, Crystal Mackall, Lori Muffly, David Miklos
Publikováno v:
HemaSphere, Vol 7, p e3362169 (2023)
Externí odkaz:
https://doaj.org/article/f37aa0e9cdbc48e78c6c20ac96a00324
Autor:
Waleed Alduaij, Caroline J. McNamara, Andre Schuh, Andrea Arruda, Mahadeo Sukhai, Nisha Kanwar, Mariam Thomas, Jay Spiegel, James A. Kennedy, Tracy Stockley, Hubert Tsui, Rebecca Devlin, Hassan Sibai, Dawn Maze, Aaron Schimmer, Karen Yee, Steven Chan, Suzanne Kamel-Reid, Vikas Gupta
Publikováno v:
HemaSphere, Vol 2, Iss 3 (2018)
Abstract. Although next-generation sequencing (NGS) has helped characterize the complex genomic landscape of myeloid malignancies, its clinical utility remains undefined. This has resulted in variable funding for NGS testing, limiting its accessibili
Externí odkaz:
https://doaj.org/article/ef9dc5c3d5384ca9aa0df67a4ad0775a
Autor:
Sammita Satyanarayan, Jay Spiegel, Dominic Hovsepian, Matthew Markert, Reena Thomas, Lori Muffly, David Miklos, Kevin Graber, Brian J. Scott
Publikováno v:
The Neurohospitalist. 13(1)
Background and Purpose Immune Cell Effector Associated Neurotoxicity Syndrome (ICANS) is common amongst patients receiving CD19 targeted Chimeric Antigen Receptor T-cell (CAR-T) therapy. The purpose of this study is to characterize the incidence of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2daa950b2ce8246c2c25aff92bb2dc38
https://pubmed.ncbi.nlm.nih.gov/36531846
https://pubmed.ncbi.nlm.nih.gov/36531846
Autor:
Cara L. Benjamin, Shreena Desai, Denise Pereira, Amer Beitinjaneh, Antonio Jimenez, Mark Goodman, Lazaros Lekakis, Jay Spiegel, Krishna V. Komanduri, Trent P. Wang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfd9039f0aab3e516a148190caf4ecf
https://doi.org/10.2139/ssrn.4395603
https://doi.org/10.2139/ssrn.4395603
Autor:
Hrishikesh K. Srinagesh, John Baird, Shabnum Patel, Agnes Reschke, Juliana Craig, Jay Spiegel, Sushma Bharadwaj, Zachary Ehlinger, Harshini Chinnasamy, Sheren F. Younes, Jean S. Oak, Yasodha Natkunam, Warren D. Reynolds, Maria Iglesias, Emma Crawford, Emily Egeler, Liora Michal Schultz, Sneha Ramakrishna, Kara L Davis, Bita Sahaf, Steven Feldman, Crystal Mackall, David B. Miklos, Lori Muffly, Matthew J. Frank
Publikováno v:
Transplantation and Cellular Therapy. 28:S162-S163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90da7a59f30517d1ac543aa44ba0d3b5
https://doi.org/10.1016/s2666-6367(22)00359-1
https://doi.org/10.1016/s2666-6367(22)00359-1
Autor:
Karen W.L. Yee, Vikas Gupta, Andrea Arruda, Nisha Kanwar, Hassan Sibai, Tracy Stockley, Dawn Maze, James A. Kennedy, Mariam Thomas, Andre C. Schuh, Caroline J McNamara, Aaron D. Schimmer, Suzanne Kamel-Reid, Jay Spiegel, Mahadeo A. Sukhai, Steven M. Chan, Rebecca Devlin, Waleed Alduaij, Hubert Tsui
Publikováno v:
HemaSphere, Vol 2, Iss 3 (2018)
HemaSphere
HemaSphere
Supplemental Digital Content is available in the text
Although next-generation sequencing (NGS) has helped characterize the complex genomic landscape of myeloid malignancies, its clinical utility remains undefined. This has resulted in variable
Although next-generation sequencing (NGS) has helped characterize the complex genomic landscape of myeloid malignancies, its clinical utility remains undefined. This has resulted in variable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c5d99ede4bf66f8597e8c720ad6542d
http://journals.lww.com/10.1097/HS9.0000000000000044
http://journals.lww.com/10.1097/HS9.0000000000000044
Autor:
Jay Spiegel, Caroline Jane McNamara, Andrea Arruda, Tony Panzarella, James A. Kennedy, Tracy L. Stockley, Mahadeo Sukhai, Mariam Thomas, Justyna Bartoszko, Jenny M. Ho, Nancy Siddiq, Aaron D. Schimmer, Andre C. Schuh, Hassan Sibai, Karen W.L. Yee, Jaime O. Claudio, Rebecca Devlin, Mark D. Minden, Suzanne Kamel-Reid, Vikas Gupta
Publikováno v:
Blood. 128:4263-4263
Introduction: The advent of next generation sequencing (NGS) has brought intense interest to the complex genetic landscape of myeloproliferative neoplasms (MPN). However, data regarding clinical outcomes in the context of novel MPN therapies such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e45463c477b76606d92a10eafe84524
https://doi.org/10.1182/blood.v128.22.4263.4263
https://doi.org/10.1182/blood.v128.22.4263.4263